CLINICAL_TRIALS
research
· 2025-12-31
Clinical Trial Update: Study for the Treatment for CLN7 Disease [Phase 1]
Summary
Phase 1 clinical trial for neuronal ceroid lipofuscinosis type 7 (CLN7) is listed as active but not recruiting. The sponsor is Benjamin Greenberg.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Benjamin Greenberg | Conditions: CLN7 | Phase 1 | Status: ACTIVE_NOT_RECRUITING